Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM
12:10pm, Friday, 15'th May 2026
BioNTech NASDAQ: BNTX used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a rest
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
01:15pm, Wednesday, 13'th May 2026
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.
BioNTech Announces New ADS Repurchase Program
06:45am, Thursday, 07'th May 2026
MAINZ, Germany, May 7, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that it has authorized a new share repurchase program (the “Program�
BioNTech Q3 Earnings Review: Getting Into The Weeds With Bewildering Oncology Plans
03:57pm, Wednesday, 06'th May 2026
BioNTech SE is downgraded to Sell due to declining COVID vaccine revenues, leadership exits, and pipeline uncertainty. BNTX faces €531.9m Q1 net loss, expects €2–3bn 2026 revenues, and plans €
Germany says vaccine supply secure despite BioNTech production loss
07:44am, Wednesday, 06'th May 2026
A German government spokesperson said on Wednesday that the loss of BioNTech vaccine production in the country can be offset by other companies.
BioNTech SE (BNTX) Q1 2026 Earnings Call Transcript
03:21pm, Tuesday, 05'th May 2026
BioNTech SE (BNTX) Q1 2026 Earnings Call Transcript
BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape
12:18pm, Tuesday, 05'th May 2026
Shares of BioNTech SE (NASDAQ:BNTX) are trading lower on Tuesday as the company reported mixed first-quarter financial results.
BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push
07:26am, Tuesday, 05'th May 2026
The company said it would exit operations at some manufacturing plants in Germany and Singapore, as well as sites it acquired as part of its CureVac takeover.
BioNTech to close sites in Germany, Singapore affecting 1,860 staff
06:47am, Tuesday, 05'th May 2026
Germany's BioNTech said on Tuesday it would close sites affecting up to 1,860 jobs and buy back up to $1 billion worth of its shares, following the announcement of two co-founders quitting the C
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
06:45am, Tuesday, 05'th May 2026
BioNTech SE (Nasdaq: BNTX) today reported financial results for the three months ended March 31, 2026 and provided an update on its corporate progress.
Stock Market Today (LIVE): Tesla Beats but Shares Fall on $25 Billion Capex Surprise as Iran Breakdown Sends Oil Back Above $103
09:37am, Thursday, 23'rd Apr 2026
Top insights from the latest market news from Thursday, April 23, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains?
11:10am, Wednesday, 22'nd Apr 2026
BioNTech (BNTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Two experimental drugs showed striking early results against pancreatic cancer
05:35pm, Tuesday, 21'st Apr 2026
Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
06:45am, Tuesday, 21'st Apr 2026
MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2
2 Healthcare Stocks to Buy and 1 to Approach With Caution
05:00pm, Wednesday, 15'th Apr 2026
Zoetis has strong growth prospects and an attractive income program. BioNTech has a rich pipeline that could help jolt the stock as it makes clinical progress.
